BIOTRONIK is releasing the Orsiro, the world’s first Hybrid Drug-Eluting stent, in the French market. The device features a passive proBIO Coating that isolates the stent’s metal from the vessel walls, and an active BIOlute biocompatible Coating that releases a limus to prevent reste**sis.
The combination Coating sits over the company’s PRO-Kinetic Energy Stent architecture which BIOTRONIK touts as having thin struts and excellent deliverability.
“We are happy to an**unce that the Orsiro Hybrid DES, one of three Stent systems in the BIOTRONIK Masterpieces portfolio along with the PRO-Kinetic Energy bare metal Stent and the PK Papyrus covered stent, will **w be Available to yet a**ther patient population that needs it,” Dr. Alexander Uhl, Vice President of Marketing, BIOTRONIK Vascular Intervention, said in a statement. “Physicians rely on top performing tools for each and every procedure. We see the launch of Orsiro in France as a crucial step towards giving an even greater number of physicians worldwide the chance to work with a tool that we consider a Masterpiece.”
10-11-2014, 12:40 AM
Orsiro Stent with Hybrid Drug-Eluting Coating **w Available in France
العرض العادي
